BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28356023)

  • 1. The Cross-talk between Tristetraprolin and Cytokines in Cancer.
    Guo J; Wang H; Jiang S; Xia J; Jin S
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1477-1486. PubMed ID: 28356023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tristetraprolin in cancer and inflammation.
    Sanduja S; Blanco FF; Young LE; Kaza V; Dixon DA
    Front Biosci (Landmark Ed); 2012 Jan; 17(1):174-88. PubMed ID: 22201737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of mRNA decay by phosphorylation of tristetraprolin.
    Sandler H; Stoecklin G
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):491-6. PubMed ID: 18481987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of RNA-binding protein tristetraprolin in cancer and immunity.
    Guo J; Qu H; Chen Y; Xia J
    Med Oncol; 2017 Nov; 34(12):196. PubMed ID: 29124478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tristetraprolin-RNA interaction map reveals a novel TTP-RelB regulatory network for innate immunity gene expression.
    Tu Y; Wu X; Yu F; Dang J; Wei Y; Yu H; Liao W; Zhang Y; Wang J
    Mol Immunol; 2020 May; 121():59-71. PubMed ID: 32163759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3'UTR AU-Rich Elements (AREs) and the RNA-Binding Protein Tristetraprolin (TTP) Are Not Required for the LPS-Mediated Destabilization of Phospholipase-Cβ-2 mRNA in Murine Macrophages.
    Shukla S; Elson G; Blackshear PJ; Lutz CS; Leibovich SJ
    Inflammation; 2017 Apr; 40(2):645-656. PubMed ID: 28124257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Tristetraprolin in Tumorigenesis.
    Park JM; Lee TH; Kang TH
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bi-phased regulation of the post-transcriptional inflammatory response by Tristetraprolin levels.
    Mahmoud L; Moghrabi W; Khabar KSA; Hitti EG
    RNA Biol; 2019 Mar; 16(3):309-319. PubMed ID: 30664390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of TTP and HuR plays an important role in cancers.
    Wang H; Ding N; Guo J; Xia J; Ruan Y
    Tumour Biol; 2016 Nov; 37(11):14451-14461. PubMed ID: 27644249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment of the 4EHP-GYF2 cap-binding complex to tetraproline motifs of tristetraprolin promotes repression and degradation of mRNAs with AU-rich elements.
    Fu R; Olsen MT; Webb K; Bennett EJ; Lykke-Andersen J
    RNA; 2016 Mar; 22(3):373-82. PubMed ID: 26763119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tristetraprolin controls the stability of cIAP2 mRNA through binding to the 3'UTR of cIAP2 mRNA.
    Kim CW; Kim HK; Vo MT; Lee HH; Kim HJ; Min YJ; Cho WJ; Park JW
    Biochem Biophys Res Commun; 2010 Sep; 400(1):46-52. PubMed ID: 20691152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways.
    Deleault KM; Skinner SJ; Brooks SA
    Mol Immunol; 2008 Jan; 45(1):13-24. PubMed ID: 17606294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells.
    Kim DJ; Jang JH; Ham SY; Choi SH; Park SS; Jeong SY; Kim BC; Jeon DY; Lee BJ; Ko BK; Park JW; Cho WJ
    Biochem Biophys Res Commun; 2020 Feb; 522(2):402-407. PubMed ID: 31767150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tristetraprolin posttranscriptionally downregulates PFKFB3 in cancer cells.
    Jang JH; Kim DJ; Ham SY; Vo MT; Jeong SY; Choi SH; Park SS; Jeon DY; Lee BJ; Ko BK; Cho WJ; Park JW
    Biochem Biophys Res Commun; 2020 Jan; 521(2):389-394. PubMed ID: 31668919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
    Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G
    Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tristetraprolin Recruits Eukaryotic Initiation Factor 4E2 To Repress Translation of AU-Rich Element-Containing mRNAs.
    Tao X; Gao G
    Mol Cell Biol; 2015 Nov; 35(22):3921-32. PubMed ID: 26370510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of immediate early gene expression by tristetraprolin in the differentiation of 3T3-L1 cells.
    Lin NY; Lin CT; Chang CJ
    Biochem Biophys Res Commun; 2008 Jan; 365(1):69-74. PubMed ID: 17971298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tristetraprolin Limits Inflammatory Cytokine Production in Tumor-Associated Macrophages in an mRNA Decay-Independent Manner.
    Kratochvill F; Gratz N; Qualls JE; Van De Velde LA; Chi H; Kovarik P; Murray PJ
    Cancer Res; 2015 Aug; 75(15):3054-64. PubMed ID: 26183929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tristetraprolin down-regulates IL-23 expression in colon cancer cells.
    Lee HH; Yang SS; Vo MT; Cho WJ; Lee BJ; Leem SH; Lee SH; Cha HJ; Park JW
    Mol Cells; 2013 Dec; 36(6):571-6. PubMed ID: 24292977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tristetraprolin down-regulates IL-17 through mRNA destabilization.
    Lee HH; Yoon NA; Vo MT; Kim CW; Woo JM; Cha HJ; Cho YW; Lee BJ; Cho WJ; Park JW
    FEBS Lett; 2012 Jan; 586(1):41-6. PubMed ID: 22138182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.